gene editing
![Vertex Readies for exa-cel Launch, Cautiously Eyes Enormous Opportunity](https://pharmtales.com/wp-content/uploads/2023/11/Vertex-Gears-Up-for-exa-cel-Launch-Acknowledges-Vast-Opportunity-with-Cautious-Outlook.jpg)
Vertex Gears Up for exa-cel Launch, Acknowledges Vast Opportunity with Cautious Outlook
Anika Sharma
After a prolonged journey in development, the first CRISPR-based gene editing therapy has recently received approval from an FDA advisory ...
![CRISPR-Vertex’s gene editing therapy faces FDA committee review](https://pharmtales.com/wp-content/uploads/2023/10/CRISPR-Vertexs-gene-editing-therapy-faces-FDA-committee-review.jpg)
CRISPR-Vertex’s gene editing therapy faces FDA committee review
Anika Sharma
A significant milestone in the pharmaceutical industry is on the horizon as an FDA advisory committee prepares to review the ...